 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 03/18/2024 |
$32.46 |
$32.48 |
$32.45 |
$32.46 |
3.47M | | 03/19/2024 |
$32.47 |
$32.48 |
$32.46 |
$32.48 |
2.37M | | 03/20/2024 |
$32.49 |
$32.49 |
$32.47 |
$32.47 |
1.52M | | 03/21/2024 |
$32.49 |
$32.50 |
$32.48 |
$32.48 |
8.36M | | 03/22/2024 |
$32.48 |
$32.48 |
$32.48 |
$32.48 |
0 |
|
|
| CymaBay Therapeutics is a clinical-stage biopharmaceutical company focused on developing and providing access to therapies for patients with liver and other chronic diseases. Co.'s pipeline includes the following clinical stage product candidates: seladelpar, a selective agonist for the peroxisome proliferator-activated receptor delta, which is a nuclear receptor that regulates genes involved in bile acid/sterol, lipid, and glucose metabolism, and regulation of certain inflammatory cells; and MBX-2982, which targets G protein-coupled receptor 119 (GPR119), a receptor that interacts with bioactive lipids known to stimulate glucose-dependent insulin secretion. | |
|
Cymabay Therapeutics (CBAY) has the following price history information. Looking back at CBAY historical stock prices for the last five trading days, on March 18, 2024, CBAY opened at $32.46, traded as high as $32.48 and as low as $32.45, and closed at $32.46. Trading volume was a total of 3.47M shares. On March 19, 2024, CBAY opened at $32.47, traded as high as $32.48 and as low as $32.46, and closed at $32.48. Trading volume was a total of 2.37M shares. On March 20, 2024, CBAY opened at $32.49, traded as high as $32.49 and as low as $32.47, and closed at $32.47. Trading volume was a total of 1.52M shares. On March 21, 2024, CBAY opened at $32.49, traded as high as $32.50 and as low as $32.48, and closed at $32.48. Trading volume was a total of 8.36M shares. On March 22, 2024, CBAY opened at $32.48, traded as high as $32.48 and as low as $32.48, and closed at $32.48. Trading volume was a total of 0 shares.
CBAY Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Cymabay Therapeutics shares, starting with a $10,000 purchase of CBAY, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
04/22/2014 |
|
| End date: |
03/22/2024 |
|
| Start price/share: |
$5.50 |
|
| End price/share: |
$32.48 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
490.55% |
|
| Average Annual Total Return: |
19.60% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$59,067.54 |
|
| Years: |
9.92 |
|
|
|
| Date |
Close |
| 03/18/2024 | $32.46 | | 03/19/2024 | $32.48 | | 03/20/2024 | $32.47 | | 03/21/2024 | $32.48 | | 03/22/2024 | $32.48 |
|
|
Free CBAY Email Alerts:
